연구
-
-
연구
-
연구업적
연구업적
최근 5년 연구업적 현황
| 연도 | 2024년 | 2023년 | 2022년 | 2021년 | 2020년 | |
|---|---|---|---|---|---|---|
| SCI 논문 발표편수 |
책임 | 179편 | 173편 | 163편 | 184편 | 135편 |
| 공동 | 147편 | 120편 | 115편 | 136편 | 168편 | |
| 합계 | 326편 | 293편 | 278편 | 320편 | 303편 | |
1927. Integrative analysis of mutational and transcriptional profiles reveals driver mutations of metastatic breast cancers.
Lee JH, Zhao XM, Yoon I, Lee JY, Kwon NH, Wang YY, Lee KM, Lee M4, Kim J, Moon HG, In Y, Hao JK, Park KM, Noh DY, Han WS, Kim S.
Cell Discov. 2016 Aug 30;2:16025. doi: 10.1038/celldisc.2016.25. eCollection 2016.
Link
1926. Factors associated with late recurrence after completion of 5-year adjuvant tamoxifen in estrogen receptor positive breast cancer.
Lee ES, Han WS, Kim MK, Kim J, Yoo TK, Lee MH, Lee KH, Kim TY, Moon HG, Im SA, Noh DY, Lee ES.
BMC Cancer. 2016 Jul 7;16:430. doi: 10.1186/s12885-016-2423-x.
Link
1925. Enhanced anti-tumor activity and cytotoxic effect on cancer stem cell population of metformin-butyrate compared with metformin HCl in breast cancer.
Lee KM, Lee M, Lee J, Kim SW, Moon HG, Noh DY, Han WS.
Oncotarget. 2016 Jun 21;7(25):38500-38512. doi: 10.18632/oncotarget.9522.
Link
1924. Oncologic Safety of Immediate Breast Reconstruction for Invasive Breast Cancer Patients: A Matched Case Control Study.
Park SH, Han WS, Yoo TK, Lee HB, Jin US, Chang H, Minn KW, Noh DY.
J Breast Cancer. 2016 Mar;19(1):68-75. doi: 10.4048/jbc.2016.19.1.68. Epub 2016 Mar 25.
Link
1923. Delay of Treatment Initiation Does Not Adversely Affect Survival Outcome in Breast Cancer.
Yoo TK, Han WS, Moon HG, Kim J, Lee JW, Kim MK, Lee E, Kim J, Noh DY.
Cancer Res Treat. 2016 Jul;48(3):962-9. doi: 10.4143/crt.2015.173. Epub 2015 Oct 22.
Link
1922. Total lesion glycolysis (TLG) as an imaging biomarker in metastatic colorectal cancer patients treated with regorafenib.
Lim Y, Bang JI, Han SW, Paeng JC, Lee KH, Kim JH, Kang GH, Jeong SY, Park KJ, Kim TY.
Eur J Nucl Med Mol Imaging. 2016 Nov 25. [Epub ahead of print]
Link
1921. Adverse prognostic impact of the CpG island methylator phenotype in metastatic colorectal cancer.
Cha Y, Kim KJ, Han SW, Rhee YY, Bae JM, Wen X, Cho NY, Lee DW, Lee KH, Kim TY, Oh DY, Im SA, Bang YJ, Jeong SY, Park KJ, Kang GH, Kim TY.
Br J Cancer. 2016 Jul 12;115(2):164-71. doi: 10.1038/bjc.2016.176. Epub 2016 Jun 16.
Link
1920. Splenomegaly and Its Associations with Genetic Polymorphisms and Treatment Outcome in Colorectal Cancer Patients Treated with Adjuvant FOLFOX.
Kim MJ, Han SW, Lee DW, Cha Y, Lee KH, Kim TY, Oh DY, Kim SH, Im SA, Bang YJ, Kim TY.
Cancer Res Treat. 2016 Jul;48(3):990-7. doi: 10.4143/crt.2015.296. Epub 2016 Jan 14.
Link
1919. Plasmablastic lymphoma exclusively involving bones mimicking osteosarcoma in an immunocompetent patient: A case report.
Sarker AK, Im HJ, Paeng JC, Cheon GJ, Kang KW, Chung JK, Lee DS.
Medicine (Baltimore). 2016 Jul;95(28):e4241. doi: 10.1097/MD.0000000000004241.
Link
1918. Association between partial-volume corrected SUVmax and Oncotype DX recurrence score in early-stage, ER-positive/HER2-negative invasive breast cancer.
Lee SH, Ha S, An HJ, Lee JS, Han W, Im SA, Ryu HS, Kim WH, Chang JM, Cho N, Moon WK, Cheon GJ.
Eur J Nucl Med Mol Imaging. 2016 Aug;43(9):1574-84. doi: 10.1007/s00259-016-3418-1. Epub 2016 May 21.
Link